| abstract |
This disclosure relates to nicotine receptor agonists or analogs or derivatives represented by the formula shown, wherein R1, R2, Xa and Ya are as defined in the specification. The use of nicotine receptor agonists or analogs or derivatives thereof for treating inflammatory pulmonary diseases is also disclosed. The disclosure further relates to pharmaceutical compositions comprising nicotine receptor agonists or analogs or derivatives thereof. |